(Q44863417)

6 December 2017

1 reference

title

The role of voriconazole in the treatment of emerging mycoses (English)

1 reference

6 December 2017

1 reference

2

Josep Guarro

1 reference

6 December 2017

F Javier Pastor

1

1 reference

6 December 2017

publication date

1 September 2007

1 reference

Revista iberoamericana de micologia

6 December 2017

published in

1 reference

6 December 2017

volume

24

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

228-232

1 reference

Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Topical and oral voriconazole in the treatment of fungal keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Pulmonary Pseudallescheria boydii infection with cutaneous zygomycosis after near drowning

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Scedosporium prolificans: an uncommon cause of septic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Scedosporium apiospermum soft-tissue infection: a case report and review of kidney transplant literature.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Antifungal susceptibilities of the species of the Pseudallescheria boydii complex

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Use of voriconazole in treatment of Scedosporium apiospermum infection: case report

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Voriconazole for candidosis: an important addition?

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Treating disseminated fusariosis: amphotericin B, voriconazole or both?

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

1 reference

7 January 2021

Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Clinical pharmacokinetics of voriconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Treatment of Cutaneous Infection by Alternaria alternata With Voriconazole in a Liver Transplant Patient

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Phenotypic switching in Candida lusitaniae on copper sulfate indicator agar: association with amphotericin B resistance and filamentation

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Posttraumatic Aspergillus terreus endophthalmitis masquerading as dispersed lens fragments

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Successful treatment of multiple Pseudallescheria boydii brain abscesses and ventriculitis/ependymitis in a 2-year-old child after a near-drowning episode

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Fusarium infection in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Voriconazole salvage treatment of invasive candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Voriconazole in the management of Alternaria keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Clinical significance of azole antifungal drug cross-resistance in Candida glabrata

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Advances and challenges in management of invasive mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Epidemiology of invasive candidiasis: a persistent public health problem

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Successful treatment of disseminated fusariosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Anterior chamber exudative mass due to Scedosporium apiospermum in an immunocompetent individual.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Current treatment strategies for disseminated candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Successful treatment of brain aspergillosis with voriconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1406%2807%2970048-7

7 January 2021

10.1016/S1130-1406(07)70048-7

Identifiers

DOI

1 reference

6 December 2017

1 reference